National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results

< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
Related Pages
Childhood Cancers Home Page
NCI's gateway for information about pediatric cancers.

Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.
Childhood Cancer Trial Results
6.  Young Children with Medulloblastoma May Be Able to Avoid Post-Surgery Radiotherapy
(Posted: 03/21/2005) - Children younger than three with a kind of brain cancer called medulloblastoma may be effectively treated with chemotherapy alone after surgery, according to a report released by the New England Journal of Medicine on March 10, 2005.

7.  Improved Survival for Those With Ewing Sarcoma
(Posted: 02/27/2003, Reviewed: 02/01/2005) - Addition of the drugs ifosfamide and etoposide to standard chemotherapy for Ewing sarcoma significantly improved five-year survival in patients whose disease had not spread to other organs, according to the February 20, 2003, issue of the New England Journal of Medicine.

8.  Alternate Drug Less Toxic, Less Effective Than Standard Treatment for ALL
(Posted: 05/20/2002, Reviewed: 03/15/2006) - Acute lymphoblastic leukemia (ALL) is the most common cancer in children. Now two new studies suggest that, given at the same dose, the standard E. coli form of the drug asparaginase -- a mainstay for more than 30 years in the treatment of ALL -- appears to be more effective, though more toxic, than another form known as Erwinia asparaginase.

9.  High Doses of Chemotherapy Drug Lead to Better Survival for Children with Leukemia and Lymphoma
(Posted: 05/14/2001, Reviewed: 03/15/2006) - Results of a clinical trial indicated that higher doses of a common chemotherapy drug, methotrexate, may lead to less recurrences of a certain type of leukemia and lymphoma in children.

10.  Less Chemotherapy Needed for Wilms Tumor Patients
(Posted: 05/01/1999, Reviewed: 02/01/2005) - People with Wilms tumor (a cancer of the kidney that most commonly occurs in children) can now receive fewer chemotherapy treatments with fewer side effects, according to a report in the January 1998 issue of the Journal of Clinical Oncology.
< Previous  1 2 

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov